Life Tech Rips Promega Bid To Rethink US Damages In IP Row
Life Technologies Corp. on Monday urged the Federal Circuit to uphold its finding that Promega Corp. doesn't deserve U.S.-specific damages in patent litigation over genetic-testing kits, despite pleas from Promega for...To view the full article, register now.
Already a subscriber? Click here to view full article